These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 210151)

  • 21. Effect of polymyxin B on kappa phage adsorption on Serratia marcescens HY.
    Patel KA; Patel IR; Mehta AM; Dave PJ
    Indian J Exp Biol; 1980 Nov; 18(11):1353-4. PubMed ID: 6260637
    [No Abstract]   [Full Text] [Related]  

  • 22. Outer membrane proteins of polymyxin resistant Pseudomonas aeruginosa: effect of magnesium depletion.
    Shand GH; Anwar H; Brown MR
    J Antimicrob Chemother; 1988 Dec; 22(6):811-21. PubMed ID: 2854118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.
    Ostenson RC; Fields BT; Nolan CM
    Antimicrob Agents Chemother; 1977 Dec; 12(6):655-9. PubMed ID: 201214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism.
    Gilleland HE; Farley LB
    Can J Microbiol; 1982 Jul; 28(7):830-40. PubMed ID: 6293694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of polymyxin B on prodigiosin biosynthesis in Serratia marcescens.
    Tsang JC; Sheung X
    J Antibiot (Tokyo); 1980 Apr; 33(4):455-7. PubMed ID: 6251020
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa.
    Moore RA; Chan L; Hancock RE
    Antimicrob Agents Chemother; 1984 Oct; 26(4):539-45. PubMed ID: 6097168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.
    Traub WH; Kleber I
    Chemotherapy; 1975; 21(3-4):189-204. PubMed ID: 169108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse relationship between the flagella formation and prodigiosin synthesis in Serratia marcescens.
    Kobayashi N; Ichikawa Y
    Microbiol Immunol; 1990; 34(4):347-54. PubMed ID: 2113984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of carbon sources on chemical composition of cell envelopes of Pseudomonas aeruginosa in association with polymyxin resistance.
    Gilleland HE; Conrad RS
    Antimicrob Agents Chemother; 1980 Apr; 17(4):623-8. PubMed ID: 6249193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium.
    Peterson AA; Fesik SW; McGroarty EJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):230-7. PubMed ID: 3032093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different mechanisms of resistance to latamoxef (moxalactam) in Serratia marcescens.
    Gutmann L; Chabbert YA
    J Antimicrob Chemother; 1984 Jan; 13(1):15-22. PubMed ID: 6365875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleiotropic consequences of mutations towards antibiotic-hypersensitivity in Serratia marcescens.
    Winkler U; Heller KB; Folle B
    Arch Microbiol; 1978 Mar; 116(3):259-68. PubMed ID: 348145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts.
    Freer E; Moreno E; Moriyón I; Pizarro-Cerdá J; Weintraub A; Gorvel JP
    J Bacteriol; 1996 Oct; 178(20):5867-76. PubMed ID: 8830680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent reduction of lipopolysaccharide pyrogenicity by polymyxin B.
    Warner SJ; Mitchell D; Savage N; McClain E
    Biochem Pharmacol; 1985 Nov; 34(22):3995-8. PubMed ID: 2998395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
    Traub WH; Kleber I
    Antimicrob Agents Chemother; 1975 Jun; 7(6):874-6. PubMed ID: 168807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis.
    Kaca W; Radziejewska-Lebrecht J; Bhat UR
    Microbios; 1990; 61(246):23-32. PubMed ID: 2156134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic polymyxin arranges lipopolysaccharide into crystalline structures to solidify the bacterial membrane.
    Manioglu S; Modaresi SM; Ritzmann N; Thoma J; Overall SA; Harms A; Upert G; Luther A; Barnes AB; Obrecht D; Müller DJ; Hiller S
    Nat Commun; 2022 Oct; 13(1):6195. PubMed ID: 36271003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyocin-resistant lipopolysaccharide mutans of Neisseria gonorrhoeae: alterations in sensitivity to normal human serum and polymyxin B.
    Guymon LF; Esser M; Shafer WM
    Infect Immun; 1982 May; 36(2):541-7. PubMed ID: 6282751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of polymyxin B-mediated lysis of lipopolysaccharide-treated erythrocytes.
    Carr C; Morrison DC
    Infect Immun; 1985 Jul; 49(1):84-9. PubMed ID: 2989182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1.
    Nicas TI; Hancock RE
    J Gen Microbiol; 1983 Feb; 129(2):509-17. PubMed ID: 6302204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.